Skip to main content
Erschienen in: Comparative Clinical Pathology 6/2017

20.08.2017 | Original Article

TNFα gene polymorphism in steroid resistant nephrotic syndrome

verfasst von: Lamiaa Abd El-Lateaf Ali Barakat, Faten Zahran Mohamed, Mohamed Magdy Zedan, Mohamed Adel Abd El-Motelb El-Eshmawy, Mona Abo Bakr El-Hussiny

Erschienen in: Comparative Clinical Pathology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Cytokines play a main role as progressive factors in nephrotic syndrome (NS). Tumor necrosis factor alpha (TNFα) produced by activated macrophages is often accompanied by pro inflammatory properties. Some cytokine gene polymorphisms like TNFα have associated with various inflammatory diseases as glomerulonephritis. The aim of the current work was to investigate the serum level of TNFα and the association between TNFα G308A polymorphism and the response to steroid therapy in nephrotic syndrome. This study was conducted on 250 subjects, 100 healthy children, 50 steroid sensitive nephrotic syndrome (SSNS), and 100 steroid resistant nephrotic syndrome patients (SRNS). Serum concentration of TNFα was measured by enzyme-linked immunosorbent assay (ELISA) technique and TNFα-G308A gene polymorphism was estimated by polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP). Serum concentrations of TNFα significantly increased in SRNS cases when compared to SSNS subgroups. TNF GA, AA, GA + AA genotypes and A allele showed significant association with risk of NS development within healthy control subjects. TNFα-G308A genotypes and alleles did not differ significantly between SSNS and SRNS groups.
Literatur
Zurück zum Zitat Ahmad H, Tejani A (2000) Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 84:342–346CrossRefPubMed Ahmad H, Tejani A (2000) Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 84:342–346CrossRefPubMed
Zurück zum Zitat Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig 81:1503–1515CrossRefPubMed Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR (2001) Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Investig 81:1503–1515CrossRefPubMed
Zurück zum Zitat Aten J, Roos A, Claessen N, Schilder Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438PubMed Aten J, Roos A, Claessen N, Schilder Tol EJ, Ten Berge IJ, Weening JJ (2000) Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 11:1426–1438PubMed
Zurück zum Zitat Baud L, Ardaillou R (1995) Tumour necrosis factor in renal injury. Miner Electrolyte Metab 21:336–341PubMed Baud L, Ardaillou R (1995) Tumour necrosis factor in renal injury. Miner Electrolyte Metab 21:336–341PubMed
Zurück zum Zitat Chen SP, Cheung W, Heng CK, Jordan SC, Yap HK (2003) Childhood nephrotic syndrome in relapse is associated with down regulation of monocyte CD14 expression and lipopolysaccharide induced tumour necrosis factor α production. Clin Exp Immunol 134:111–119CrossRefPubMedPubMedCentral Chen SP, Cheung W, Heng CK, Jordan SC, Yap HK (2003) Childhood nephrotic syndrome in relapse is associated with down regulation of monocyte CD14 expression and lipopolysaccharide induced tumour necrosis factor α production. Clin Exp Immunol 134:111–119CrossRefPubMedPubMedCentral
Zurück zum Zitat Ganong WF (1999) Circulating body fluids. In: Ganong WF (ed) Review of medical physiology, 19th edn. Appelton& Lange, Stamford, pp 493–521 Ganong WF (1999) Circulating body fluids. In: Ganong WF (ed) Review of medical physiology, 19th edn. Appelton& Lange, Stamford, pp 493–521
Zurück zum Zitat Giacomelli M, Kumar R, Tampella G, Ceffa S, Bontempelli M (2015) IL-4, IL-10 and TNF-α polymorphisms in idiopathic membranous nephropathy (IMN). Open J Immunol 5:233–243CrossRef Giacomelli M, Kumar R, Tampella G, Ceffa S, Bontempelli M (2015) IL-4, IL-10 and TNF-α polymorphisms in idiopathic membranous nephropathy (IMN). Open J Immunol 5:233–243CrossRef
Zurück zum Zitat Haycock G (2003) The child with idiopathic nephrotic syndrome. In: Nicholas JA, Postlethwaite RJ (eds) Clinical Paediatric nephrology, 3rd edn. Oxford, New York, pp 341–366 Haycock G (2003) The child with idiopathic nephrotic syndrome. In: Nicholas JA, Postlethwaite RJ (eds) Clinical Paediatric nephrology, 3rd edn. Oxford, New York, pp 341–366
Zurück zum Zitat Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/ tumour necrosis factor receptor super family: players, rules and the games. Immunology 115:1–20CrossRefPubMedPubMedCentral Hehlgans T, Pfeffer K (2005) The intriguing biology of the tumour necrosis factor/ tumour necrosis factor receptor super family: players, rules and the games. Immunology 115:1–20CrossRefPubMedPubMedCentral
Zurück zum Zitat Jafar T, Agrawal S, Mahdi AA, Sharma RK, Awasthi S, Agarwal GG (2011) Cytokine gene polymorphism in idiopathic nephrotic syndrome children. Indian J Clin Biochem 26(3):296–302CrossRefPubMedPubMedCentral Jafar T, Agrawal S, Mahdi AA, Sharma RK, Awasthi S, Agarwal GG (2011) Cytokine gene polymorphism in idiopathic nephrotic syndrome children. Indian J Clin Biochem 26(3):296–302CrossRefPubMedPubMedCentral
Zurück zum Zitat Janeway CA, Travers P, Walport M et al (1999) T-cell mediated immunity. In: Janeway CA et al (eds) Immunobiology:the immune system in healthand disease, 4th edn. Elsevier science, New York, pp 363–415 Janeway CA, Travers P, Walport M et al (1999) T-cell mediated immunity. In: Janeway CA et al (eds) Immunobiology:the immune system in healthand disease, 4th edn. Elsevier science, New York, pp 363–415
Zurück zum Zitat Karray EF, Bendhifallah I, Ben Abdelghani K, Hamzaoui K, Zakraoui L (2011) Tumor necrosis factor gene polymorphisms and susceptibility to rheumatoid arthritis in regional Tunisian population. J Infect Dis Immun 3(2):30–35 Karray EF, Bendhifallah I, Ben Abdelghani K, Hamzaoui K, Zakraoui L (2011) Tumor necrosis factor gene polymorphisms and susceptibility to rheumatoid arthritis in regional Tunisian population. J Infect Dis Immun 3(2):30–35
Zurück zum Zitat Khan SB, Cook HT, Bhangal G, Smith J, Tam FWK, Pusey CD (2005) Antibody blockade of TNF-α reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67(5):1812–1820CrossRefPubMed Khan SB, Cook HT, Bhangal G, Smith J, Tam FWK, Pusey CD (2005) Antibody blockade of TNF-α reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67(5):1812–1820CrossRefPubMed
Zurück zum Zitat Kim SD, Park JM, Kim IS, Choi KD, Lee BC, Lee HJ, Hong MS, Chung JH, Lee TW, Ihm CG, Cho BS (2004) Association of IL-1β, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 19:295–299CrossRefPubMed Kim SD, Park JM, Kim IS, Choi KD, Lee BC, Lee HJ, Hong MS, Chung JH, Lee TW, Ihm CG, Cho BS (2004) Association of IL-1β, IL-1ra, and TNF-alpha gene polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 19:295–299CrossRefPubMed
Zurück zum Zitat Madani HA, Bazaraa HM, Rady H (2014) Association of cytokine genes polymorphisms and the response to corticosteroid therapy in children with idiopathic nephrotic syndrome: a pilot study in Egypt. Int Res J Med Sci 2(4):84–90 Madani HA, Bazaraa HM, Rady H (2014) Association of cytokine genes polymorphisms and the response to corticosteroid therapy in children with idiopathic nephrotic syndrome: a pilot study in Egypt. Int Res J Med Sci 2(4):84–90
Zurück zum Zitat Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, Jones PW, Fryer AA, Strange RC, Thompson AJ, Hawkins CP (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuro Immunol 129:197–204 Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, Jones PW, Fryer AA, Strange RC, Thompson AJ, Hawkins CP (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuro Immunol 129:197–204
Zurück zum Zitat Matsumoto K (1995) Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. Nephron 70:118–119CrossRefPubMed Matsumoto K (1995) Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. Nephron 70:118–119CrossRefPubMed
Zurück zum Zitat Orsonneau JL, Dovet P, Massoubre C, Lustenberger P, Bernard S (1989) Clin Chem 35:2233PubMed Orsonneau JL, Dovet P, Massoubre C, Lustenberger P, Bernard S (1989) Clin Chem 35:2233PubMed
Zurück zum Zitat Rizk MK, El Nawawy A, Abdel Kareem E, Amer ES, El Gezairy D, El Shafei AZ (2005) Serum interleukins and urinary micro globulin in children with idiopathic nephrotic syndrome. East Mediterr Health J 11:993–1002PubMed Rizk MK, El Nawawy A, Abdel Kareem E, Amer ES, El Gezairy D, El Shafei AZ (2005) Serum interleukins and urinary micro globulin in children with idiopathic nephrotic syndrome. East Mediterr Health J 11:993–1002PubMed
Zurück zum Zitat Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX et al (2000) Increased NF-κB and angiotensinogen gene expression in post transplant recurrent focal segmental glomerulosclerosis. Transplantation 70:1107–1110CrossRefPubMed Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX et al (2000) Increased NF-κB and angiotensinogen gene expression in post transplant recurrent focal segmental glomerulosclerosis. Transplantation 70:1107–1110CrossRefPubMed
Zurück zum Zitat Skalova S, Podhola M, Vondrak K, Chernin G (2010) Plasmapheresis induced clinical improvement in a patient with steroid resistant nephrotic syndrome due to podocin (NPHS2) gene mutation. Acta Med Austriaca 53(3):157–159 Skalova S, Podhola M, Vondrak K, Chernin G (2010) Plasmapheresis induced clinical improvement in a patient with steroid resistant nephrotic syndrome due to podocin (NPHS2) gene mutation. Acta Med Austriaca 53(3):157–159
Zurück zum Zitat Soliman NA, Aziz M, Saif El Din AM (2001) Idiopathic nephrotic syndrome: role of tumor necrosis factor – alpha. Kasr El Aini Med J 7(4):107–113 Soliman NA, Aziz M, Saif El Din AM (2001) Idiopathic nephrotic syndrome: role of tumor necrosis factor – alpha. Kasr El Aini Med J 7(4):107–113
Zurück zum Zitat Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor- α in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259CrossRefPubMed Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor- α in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259CrossRefPubMed
Zurück zum Zitat Tenbrock K, Schubert A, Stapenhorst L, Kemper MJ, Gellermann J, Timmermann K, Muller Wiefel DE, Querfeld U, Hoppe B, Michalk D (2002) Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clin Sci 102:507–512CrossRefPubMed Tenbrock K, Schubert A, Stapenhorst L, Kemper MJ, Gellermann J, Timmermann K, Muller Wiefel DE, Querfeld U, Hoppe B, Michalk D (2002) Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clin Sci 102:507–512CrossRefPubMed
Zurück zum Zitat Terlikowski SJ (2001) Tumour necrosis factor and cancer treatment: a historical review and perspectives. Rocz Akad Med Bialymst 46:5–18PubMed Terlikowski SJ (2001) Tumour necrosis factor and cancer treatment: a historical review and perspectives. Rocz Akad Med Bialymst 46:5–18PubMed
Zurück zum Zitat Tindall EA, Severi G, Hoang HN, Ma CS, Fernandez P, Southey MC, English DR, Hopper JL, Heyns CF, Tangye SG, Giles GG, Hayes VM (2010) Australian prostate cancer bio resource: comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk. Carcinogenesis 31:1748–1754CrossRefPubMed Tindall EA, Severi G, Hoang HN, Ma CS, Fernandez P, Southey MC, English DR, Hopper JL, Heyns CF, Tangye SG, Giles GG, Hayes VM (2010) Australian prostate cancer bio resource: comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk. Carcinogenesis 31:1748–1754CrossRefPubMed
Zurück zum Zitat Tripathi G, Jafar T, Mandal K, Mahdi AA, Awasthi S, Sharma RK, Kumar A, Gulati S, Agrawal S (2008) Does cytokine gene polymorphism affect steroid responses in idiopathic nephritic syndrome? Indian J Med Sci 62(10):383–391CrossRefPubMed Tripathi G, Jafar T, Mandal K, Mahdi AA, Awasthi S, Sharma RK, Kumar A, Gulati S, Agrawal S (2008) Does cytokine gene polymorphism affect steroid responses in idiopathic nephritic syndrome? Indian J Med Sci 62(10):383–391CrossRefPubMed
Zurück zum Zitat Van der Paardt M, Crusius JB, Garcia Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Pena AS, Horst Bruinsma IE (2002) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 41:1419–1423CrossRefPubMed Van der Paardt M, Crusius JB, Garcia Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Pena AS, Horst Bruinsma IE (2002) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 41:1419–1423CrossRefPubMed
Metadaten
Titel
TNFα gene polymorphism in steroid resistant nephrotic syndrome
verfasst von
Lamiaa Abd El-Lateaf Ali Barakat
Faten Zahran Mohamed
Mohamed Magdy Zedan
Mohamed Adel Abd El-Motelb El-Eshmawy
Mona Abo Bakr El-Hussiny
Publikationsdatum
20.08.2017
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 6/2017
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-017-2521-4

Weitere Artikel der Ausgabe 6/2017

Comparative Clinical Pathology 6/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie